Immunocore
IMCR
IMCR
120 hedge funds and large institutions have $2.12B invested in Immunocore in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 50 increasing their positions, 25 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 109 → 120 (+11)
5.47% more ownership
Funds ownership: 67.98% → 73.44% (+5.5%)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Holders
120
Holding in Top 10
8
Calls
$27.2M
Puts
$3.58M
Top Buyers
| 1 | +$62.4M | |
| 2 | +$31.3M | |
| 3 | +$22.8M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$19.2M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
+$8.98M |
Top Sellers
| 1 | -$11.7M | |
| 2 | -$9.89M | |
| 3 | -$8.4M | |
| 4 |
Millennium Management
New York
|
-$5.81M |
| 5 |
D.E. Shaw & Co
New York
|
-$5.67M |